Drugs / Cholecystokinin
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02497313 Comparator | Jul 2015 → Jul 2016 | type 2 diabetes mellitus | University Hospital, Gentofte, Copenhagen | Completed | No outcome recorded |
| — | NCT02445508 Comparator | May 2015 → Jul 2016 | type 2 diabetes mellitus | University Hospital, Gentofte, Copenhagen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cholecystokinin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02497313 ↗ |
| Route | Intravenous | “Intravenous infusion of cholecystokinin will be used to elicit gallbladder contraction and emptying.” NCT02445508 ↗ |